Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth N Peshkin

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Nature Communications|March 31, 2018
Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesisXiaowen Zhang, Huai-Chin Chiang, Yao Wang, et al.
Nature Communications|June 27, 2017
Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesisXiaowen Zhang, Huai-Chin Chiang, Yao Wang, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
European Journal of Human Genetics : EJHG|August 24, 2018
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Nature Communications|March 31, 2018
Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesisXiaowen Zhang, Huai-Chin Chiang, Yao Wang, et al.
Nature Communications|June 27, 2017
Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesisXiaowen Zhang, Huai-Chin Chiang, Yao Wang, et al.
Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
European Journal of Human Genetics : EJHG|August 24, 2018
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Pageof 13